首页> 外文期刊>Wiley Interdisciplinary Reviews. Membrane Transport and Signaling >Solute carrier family SLC41: what do we really know about it?
【24h】

Solute carrier family SLC41: what do we really know about it?

机译:Solute Carrier Family SLC41:我们对此有什么了解?

获取原文
获取原文并翻译 | 示例
       

摘要

The 41st family of solute carriers (SLC41) comprises three members A1, A2, and A3, which are distantly homologous to bacterial Mg2+ channel MgtE. SLC41A1 was recently characterized as being an Na+/Mg2+ exchanger (NME; a predominant cellular Mg2+-efflux system). Little is known about the exact function of SLC41A2 and SLC41A3, although, these proteins have also been linked to Mg2+ transport in human (animal) cells. The molecular biology (including membrane topology, cellular localization, transcriptomics, and proteomics) of SLC41A2 and SLC41A3 compared with SLC41A1 has only been poorly explored. Significantly more data with regard to function, functional regulation, involvement in cellular signaling, complex-forming ability, spectrum of binding partners, and involvement in the pathophysiology of human diseases are available for SLC41A1. Three recent observations namely the identification of the null mutation, c.698G>T, in SLC41A1 underlying the nephronophthisis-like phenotype, the recognition of a putative link between SLC41A1 and Parkinson's disease, and the observation that nearly 55% of preeclamptic placental samples overexpress SLC41A1, marks the protein as a possible therapeutic target of these diseases. A potential role of the SLC41 family ofMg2+ transporters in the pathophysiology of human diseases is further substantiated by the finding that SLC41A3 knockout mice develop abnormal locomotor coordination.
机译:第41个溶质载体(SLC41)家族包括三个成员A1,A2和A3,它们与细菌MG2+通道MGTE同源。 SLC41A1最近被描述为Na+/Mg2+交换器(NME;主要的细胞MG2+-Efflux系统)。对于SLC41A2和SLC41A3的确切功能知之甚少,尽管这些蛋白质也与人(动物)细胞中的MG2+转运有关。与SLC41A1相比,SLC41A2和SLC41A3的分子生物学(包括膜拓扑,细胞定位,转录组学和蛋白质组学)的探索仅受到了很差的探索。关于功能,功能调控,细胞信号传导的参与,复杂形成能力,结合伴侣的频谱以及参与人类疾病的病理生理学的数据,可用于SLC41A1,这显着更多的数据。最近的三个观察结果,即鉴定无效的c.698g> t,在SLC41A1中,类似肾脏粒细胞的表型的基础,这是对SLC41A1和帕金森氏病之间推定的联系的识别,以及近55%的先前胎盘过表达的观察结果SLC41A1,将蛋白质标记为这些疾病的可能治疗靶标。 SLC41+转运蛋白家族在人类疾病的病理生理学中的潜在作用进一步证实了SLC41A3基因敲除小鼠发展异常的运动配位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号